MM-915: Comparative Outcomes of CD38 Antibody–Containing Four-Drug Induction Strategies vs Standard Triplet Therapy in High-Risk Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis
Year: 2026
Type: conference-abstract
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7204706653
